Search Results
You are looking at 1 - 1 of 1 items for
- Author: Pengfei Ma x
- Refine by access: All content x
Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China
Search for other papers by Wenjing Wu in
Google Scholar
PubMed
Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China
Search for other papers by Jiayao Fu in
Google Scholar
PubMed
Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China
Search for other papers by Yijing Gu in
Google Scholar
PubMed
Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China
Search for other papers by Yu Wei in
Google Scholar
PubMed
Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China
Search for other papers by Pengfei Ma in
Google Scholar
PubMed
Shanghai Engineering Research Center of Tooth Restoration and Regeneration, Shanghai, China
Search for other papers by Junhua Wu in
Google Scholar
PubMed
Emerging evidence has indicated that estrogen deficiency contributes to osteoporosis by affecting the level of inflammation. The inflammation microenvironment affects many cellular physiological processes, one of which may be cellular senescence according to previous studies. Senescent cells cannot function normally and secrete inflammatory cytokines and degradative proteins, which are referred to as senescence-associated secretory phenotype (SASP) factors, inducing further senescence and inflammation. Thus, stopping this vicious cycle may be helpful for postmenopausal osteoporosis treatment. Here, we used ovariectomized (OVX) mice as an estrogen-deficient model and confirmed that OVX bone marrow mesenchymal stem cells (BMSCs) displayed a senescent phenotype and upregulated SASP factor secretion both in vitro and in vivo. Furthermore, JAK2/STAT3, an important cytokine secretion-related signalling pathway that is associated with SASP secretion, was activated. Estrogen addition and estrogen receptor blockade confirmed that the JAK2/STAT3 axis participated in OVX BMSC senescence by mediating SASP factors. And JAK inhibition reduced SASP factor expression, alleviated senescence and enhanced osteogenic differentiation. Intraperitoneal injection of a JAK inhibitor, ruxolitinib, prevented bone loss in OVX mice. Collectively, our results revealed that JAK2/STAT3 plays an important role in the inflammation-senescence-SASP feedback loop in OVX BMSCs and that JAK inhibition could be a new method for treating postmenopausal osteoporosis.